Cargando…

Prevalence of and Viral Outcomes Associated with Primary HIV-1 Drug Resistance

Primary, or transmitted, HIV antiretroviral resistance is an ongoing concern despite continuing development of new antiretroviral therapies. We examined HIV surveillance data, including both patient demographic characteristics and laboratory data, combined with HIV genotypic test results to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buskin, SE, Zhang, S, Thibault, CS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462330/ https://www.ncbi.nlm.nih.gov/pubmed/23049668 http://dx.doi.org/10.2174/1874613601206010181

Ejemplares similares

Evaluating surveillance definitions of HIV viral suppression 2015–2019: Which definition best detected barriers to care?
por: Erly, Steven, et al.
Publicado: (2023)

Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
por: Ji, Hezhao, et al.
Publicado: (2018)

Prevalence and Impact of Minority Variant Drug Resistance Mutations in Primary HIV-1 Infection
por: Stekler, Joanne D., et al.
Publicado: (2011)

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses
por: Pham, Hanh T., et al.
Publicado: (2016)

In silico analysis of drug resistance in wild type and mutant HIV-1 subtype d protease
por: Munusami, Punnagai, et al.
Publicado: (2014)

Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2016)

Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds
por: Yang, Wan-Lin, et al.
Publicado: (2015)

Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002
por: Jenwitheesuk, Ekachai, et al.
Publicado: (2003)

A public health approach to monitoring HIV with resistance to HIV pre-exposure prophylaxis
por: Buskin, Susan E., et al.
Publicado: (2022)

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
por: Mesplède, Thibault, et al.
Publicado: (2013)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

HIV-1 Diversity, Transmission Dynamics and Primary Drug Resistance in Angola
por: Bártolo, Inês, et al.
Publicado: (2014)

Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries
por: Kirichenko, Alina, et al.
Publicado: (2022)

A decade of viral mutations and associated drug resistance in a population of HIV-1(+) Puerto Ricans: 2002–2011
por: Sepúlveda-Torres, Lycely del C., et al.
Publicado: (2017)

Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006–2010
por: Sepúlveda-Torres, Lycely del C., et al.
Publicado: (2012)

Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China
por: Zhang, Huizheng, et al.
Publicado: (2023)

Moderate prevalence of HIV-1 transmitted drug resistance mutations in southern Brazil
por: Bahls, Larissa Danielle, et al.
Publicado: (2019)

Analysis of HIV-1 diversity, primary drug resistance and transmission networks in Croatia
por: Oroz, Maja, et al.
Publicado: (2019)

National Prevalence and Trends of HIV Transmitted Drug Resistance in Mexico
por: Avila-Ríos, Santiago, et al.
Publicado: (2011)

Effect of misclassification of antiretroviral treatment status on the prevalence of transmitted HIV-1 drug resistance
por: Castro, Hannah, et al.
Publicado: (2012)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique
por: Bila, Dulce Celina Adolfo, et al.
Publicado: (2015)

Prevalence and Transmission Dynamics of HIV-1 Transmitted Drug Resistance in a Southeastern Cohort
por: Levintow, Sara N, et al.
Publicado: (2018)

Viral escape in the CNS with multidrug-resistant HIV-1
por: Béguelin, Charles, et al.
Publicado: (2014)

Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China
por: Wang, Zhenyan, et al.
Publicado: (2019)

Nationwide Estimates of Viral Load Suppression and Acquired HIV Drug Resistance in Cameroon
por: Tchouwa, Gaëlle F., et al.
Publicado: (2018)

Primary drug resistance at diagnosis of HIV-1 infection: a Portuguese cohort
por: Rocha Pereira, Nuno, et al.
Publicado: (2014)

Prevalence of HIV Transmitted Drug Resistance in Nanjing from 2018 to 2021
por: Su, Yifan, et al.
Publicado: (2023)

Prevalence of drug resistance mutations in HIV-1 protease gene from North India
por: Azam, Mohd, et al.
Publicado: (2012)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Prevalence and Structure of HIV-1 Drug Resistance to Antiretrovirals in the Volga Federal District in 2008–2019
por: Peksheva, Olga, et al.
Publicado: (2022)

Use of Dried Plasma Spots for HIV-1 Viral Load Determination and Drug Resistance Genotyping in Mexican Patients
por: Rodriguez-Auad, Juan Pablo, et al.
Publicado: (2015)

HIV-1 drug-resistance and drug-dependence
por: Baldwin, Chris, et al.
Publicado: (2007)

HIV-1 Epidemiology, Genetic Diversity, and Primary Drug Resistance in the Tyumen Oblast, Russia
por: Gashnikova, Natalya M., et al.
Publicado: (2016)

Prevalence of Transmitted HIV Drug Resistance in Iran between 2010 and 2011
por: Jahanbakhsh, Fatemeh, et al.
Publicado: (2013)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Prevalence and Correlates of Pre-Treatment HIV Drug Resistance among HIV-Infected Children in Ethiopia
por: Tadesse, Birkneh Tilahun, et al.
Publicado: (2019)

Evaluating New Definitions of Acute and Early HIV Infection from HIV Surveillance Data
por: Buskin, Susan E, et al.
Publicado: (2014)

Higher prevalence of viral control in HIV-1-infected women in serodiscordant relationships
por: Peebles, Kathryn, et al.
Publicado: (2018)

HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration
por: D’Jaen, Gabriela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_m9oreobcsltfiehs5rnr2is5s2